Follow-up Study of Safety and Efficacy in Subjects Who Completed PNEUMOSTEM® Phase II (MP-CR-012) Clinical Trial

Clinical trial NCT04003857 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04003857
Sponsor: Medipost Co Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Bronchopulmonary Dysplasia BPD

Start date: 2019-07-05
Primary completion: 2027-06-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.